Key result
Transcatheter aortic valve implantation mortality and morbidity outcomes in high-risk patients with advanced aortic stenosis were evaluated at a tertiary center.
Why the study?
The study aimed to determine whether the mortality and morbidity outcomes of TAVI performed for advanced AS in high-risk patients at the authors' clinic were similar to those reported in the literature.
Does transcatheter aortic valve implantation (TAVI) improve mortality and morbidity in high-risk patients with advanced aortic stenosis?
Does transcatheter aortic valve implantation (TAVI) improve mortality and morbidity in high-risk patients with advanced aortic stenosis?
Answers are grounded in this paper and cite their sources.
Local TAVI mortality declined with experience, aligning with literature; extends single-center data but leaves generalizability open.
Objective: Transcatheter aortic valve implantation (TAVI), which is an actual treatment method for advanced aortic stenosis (AS) in high-risk patients, has been applied to many patients in our clinic. This study aimed to show whether the mortality and morbidity results of the TAVI procedure performed in our clinic were similar to those in the literature.
No takes yet. Share an insight, caveat, or question.
Fatullayev et al. (2022) studied this question. Transcatheter aortic valve implantation mortality and morbidity outcomes in high-risk patients with advanced aortic stenosis were evaluated at a tertiary center.
Synapse has enriched 10 related papers. Consider them for comparative context: